Invasive mold infections following combat-related injuries

Clinical Infectious Diseases

Volumn 55, Issue 11, 2012, Pages 1441-1449

  Warkentien, Tyler ^a   Rodriguez, Carlos ^a   Lloyd, Bradley ^b   Wells, Justin ^a   Weintrob, Amy ^a,c   Dunne, James R ^a   Ganesan, Anuradha ^a,c   Li, Ping ^c   Bradley, William ^c   Gaskins, Lakisha J ^c   Seillier Moiseiwitsch, Françoise ^c   Murray, Clinton K ^d   Millar, Eugene V ^c   Keenan, Bryan ^a   Paolino, Kristopher ^a   Fleming, Mark ^a   Hospenthal, Duane R ^d   Wortmann, Glenn W ^a   Landrum, Michael L ^c,d   Kortepeter, Mark G ^c   Tribble, David R ^c   more..

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b LANDSTUHL REGIONAL MEDICAL CENTER   (Germany)

^c Uniformed Services University of the Health Sciences   (United States)

^d SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ECHINOCANDIN; POSACONAZOLE; VORICONAZOLE;

AFGHANISTAN; ARMY; ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; BATTLE INJURY; BLAST INJURY; BLOOD TRANSFUSION; CANDIDA; CLINICAL ARTICLE; DATA COLLECTION METHOD; DEBRIDEMENT; DISEASE REGISTRY; FUNGUS CULTURE; FUNGUS ISOLATION; FUSARIUM; HISTOPATHOLOGY; HUMAN; LEG AMPUTATION; MALE; MEDICAL RECORD; MORBIDITY; MOULD; MUCORALES; NECROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REOPERATION; SAKSENAEA VASIFORMIS; SOLDIER; SYSTEMIC MYCOSIS;

ADULT; AFGHANISTAN; ANTIFUNGAL AGENTS; BLAST INJURIES; FUNGI; HUMANS; MALE; MILITARY PERSONNEL; MYCOSES; TIME FACTORS; UNITED STATES; WOUND INFECTION; YOUNG ADULT;

EID: 84869075471     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis749     Document Type: Article

References (42)

1. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41:634-53.
2. Hajdu S, Obradovic A, Presterl E, Vecsei V. Invasive mycoses following trauma. Injury 2009; 40:548-54.
3. Skiada A, Petrikkos G. Cutaneous zygomycosis. Clin Microbiol Infect 2009; 15(suppl 5):41-5.
4. Vitrat-Hincky V, Lebeau B, Bozonnet E, et al. Severe filamentous fungal infections after widespread tissue damage due to traumatic injury: six cases and review of the literature. Scand J Infect Dis 2009; 41:491-500.
5. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13:236-301.
6. Notes from the field: fatal fungal soft-tissue infections after a tornado -Joplin, Missouri, 2011. MMWR Morb Mortal Wkly Rep 2011; 60:992.
7. Belmont PJ, Schoenfeld AJ, Goodman G. Epidemiology of combat wounds in Operation Iraqi Freedom and Operation Enduring Freedom: orthopaedic burden of disease. J Surg Orthop Adv 2010; 19:2-7.
8. Murray CK, Wilkins K, Molter NC, et al. Infections complicating the care of combat casualties during operations Iraqi Freedom and Enduring Freedom. J Trauma 2011; 71:S62-73.
9. Tribble DR, Conger NG, Fraser S, et al. Infection-associated clinical outcomes in hospitalized medical evacuees following traumatic injury-Trauma Infectious Disease Outcome Study (TIDOS). J Trauma 2011; 71:S33-42.
10. Champion HR, Holcomb JB, Lawnick MM, et al. Improved characterization of combat injury. J Trauma 2010; 68:1139-50.
11. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813-21.
12. Eastridge BJ, Jenkins D, Flaherty S, Schiller H, Holcomb JB. Trauma system development in a theater of war: experiences from Operation Iraqi Freedom and Operation Enduring Freedom. J Trauma 2006; 61:1366-72; discussion 72-3.
13. Evriviades D, Jeffery S, Cubison T, Lawton G, Gill M, Mortiboy D. Shaping the military wound: issues surrounding the reconstruction of injured servicemen at the Royal Centre for Defence Medicine. Philos Trans R Soc Lond B Biol Sci 2011; 366:219-30.
14. Dismounted complex blast injury: report of the Army Dismounted Complex Blast Injury Task Force. Available at: http://www.armymedi cine.army.mil/ reports/DCBI%20Task%20Force%20Report%20(Redacted %20Final).pdf. Accessed 18 June 2011.
15. Hospenthal DR, Chung KK, Lairet K, et al. Saksenaea erythrospora infection following combat trauma. J Clin Microbiol 2011; 49:3707-9.
16. Calvano TP, Blatz PJ, Vento TJ, et al. Pythium aphanidermatum infection following combat trauma. J Clin Microbiol 2011; 49:3710-3.
17. Tully CC, Romanelli AM, Sutton DA, Wickes BL, Hospenthal DR. Fatal Actinomucor elegans var kuwaitiensis infection following combat trauma. J Clin Microbiol 2009; 47:3394-9.
18. Gomez R, Murray CK, Hospenthal DR, et al. Causes of mortality by autopsy findings of combat casualties and civilian patients admitted to a burn unit. J Am Coll Surg 2009; 208:348-54.
19. Paolino KM, Henry JA, Hospenthal DR, Wortmann GW, Hartzell JD. Invasive fungal infections following combat-related injury. Military Medicine 2012; 177:681-5.
20. Cocanour CS, Miller-Crotchett P, Reed RL 2nd, Johnson PC, Fischer RP. Mucormycosis in trauma patients. J Trauma 1992; 32:12-5.
21. Petersen K, Riddle MS, Danko JR, et al. Trauma-related infections in battlefield casualties from Iraq. Ann Surg 2007; 245:803-11.
22. Dunne JR, Riddle MS, Danko J, Hayden R, Petersen K. Blood transfusion is associated with infection and increased resource utilization in combat casualties. Am Surg 2006; 72:619-25; discussion 25-6.
23. Taylor RW, Manganaro L, O'Brien J, Trottier SJ, Parkar N, Veremakis C. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med 2002; 30:2249-54.
24. Spellberg B, Edwards J, Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005; 18:556-69.
25. Blair JE, Fredrikson LJ, Pockaj BA, Lucaire CS. Locally invasive cutaneous Apophysomyces elegans infection acquired from snapdragon patch test. Mayo Clin Proc 2002; 77:717-20.
26. Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev 2011; 24:411-45.
27. Gettleman LK, Shetty AK, Prober CG. Posttraumatic invasive Aspergillus fumigatus wound infection. Pediatr Infect Dis J 1999; 18:745-7.
28. Tarrand JJ, Lichterfeld M, Warraich I, et al. Diagnosis of invasive septate mold infections: a correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 2003; 119:854-8.
29. Lawrence RM, Hoeprich PD, Huston AC, Benson DR, Riggins RS. Quantitative microbiology of traumatic orthopedic wounds. J Clin Microbiol 1978; 8:673-5.
30. Benson DR, Riggins RS, Lawrence RM, Hoeprich PD, Huston AC, Harrison JA. Treatment of open fractures: a prospective study. J Trauma 1983; 23:25-30.
31. Chander J, Chakrabarti A, Sharma A, Saini JS, Panigarhi D. Evaluation of Calcofluor staining in the diagnosis of fungal corneal ulcer. Mycoses 1993; 36:243-5.
32. Hamer EC, Moore CB, Denning DW. Comparison of two fluorescent whiteners, Calcofluor and Blankophor, for the detection of fungal elements in clinical specimens in the diagnostic laboratory. Clin Microbiol Infect 2006; 12:181-4.
33. Maymind M, Thomas JG, Abrons HL, Riley RS. Laboratory implementation of a rapid three-stain technique for detection of microorganisms from lower respiratory specimens. J Clin Lab Anal 1996; 10:104-9.
34. Rickerts V, Mousset S, Lambrecht E, et al. Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. Clin Infect Dis 2007; 44:1078-83.
35. Hammond SP, Bialek R, Milner DA, Petschnigg EM, Baden LR, Marty FM. Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol 2011; 49:2151-3.
36. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J, Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009; 48:1743-51.
37. Moran SL, Strickland J, Shin AY. Upper-extremity mucormycosis infections in immunocompetent patients. J Hand Surg Am 2006; 31:1201-5.
38. Spellberg B, Ibrahim A, Roilides E, et al. Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis 2012; 54(suppl 1): S73-8.
39. Meletiadis J, Antachopoulos C, Stergiopoulou T, Pournaras S, Roilides EWalsh TJ. Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology. Antimicrob Agents Chemother 2007; 51:3329-37.
40. Hirsch EF. The treatment of infected wounds, Alexis Carrel's contribution to the care of wounded soldiers during World War I. J Trauma 2008; 64(suppl 3):S209-10.
41. John BV, Chamilos G, Kontoyiannis DP. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect 2005; 11:515-7.
42. Spellberg B, Ibrahim AS, Chin-Hong PV, et al. The deferasirox- AmBisome therapy for mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 2012; 67:715-22.